ArticleThe Journal of biological chemistry2011

A novel chimeric protein-based HIV-1 fusion inhibitor targeting gp41 glycoprotein with high potency and stability.

Chungen Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.